increased small intestine adenocarcinoma incidence_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0

http://metadb.riken.jp/0009309I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr

increased small intestine adenocarcinoma incidence_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 20, Sylvie Robine
  http://metadb.riken.jp/db/mgi_rdf/MGI:3053809
• mutS homolog 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:101816

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Msh2<tm2.1Rak>|Tg(Vil-cre)20Syr

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * C57BL/6 * FVB/N * SJL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased small intestine adenocarcinoma incidence
  http://purl.obolibrary.org/obo/MP_0009309

文献

http://purl.org/net/cito/citesAsAuthority

• Melanie H. Kucherlapati, et.al., An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents., Gastroenterology, 2010, 138
  http://rdf.ncbi.nlm.nih.gov/pubmed/19931261